Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:1792-1799
Published online before print April 4, 2005, doi: 10.1161/01.CIR.0000160851.41872.C6
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/14/1792    most recent
01.CIR.0000160851.41872.C6v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fan, G.-C.
Right arrow Articles by Kranias, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fan, G.-C.
Right arrow Articles by Kranias, E. G.
Related Collections
Right arrow Apoptosis
Right arrow Ischemic biology - basic studies

(Circulation. 2005;111:1792-1799.)
© 2005 American Heart Association, Inc.


Heart Failure

Novel Cardioprotective Role of a Small Heat-Shock Protein, Hsp20, Against Ischemia/Reperfusion Injury

Guo-Chang Fan, PhD; Xiaoping Ren, MD; Jiang Qian, MD; Qunying Yuan, MD; Persoulla Nicolaou, BS; Yang Wang, MD; W. Keith Jones, PhD; Guoxiang Chu, MD, PhD; Evangelia G. Kranias, PhD

From the Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Correspondence to Evangelia G. Kranias, PhD, Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0575. E-mail litsa.kranias{at}uc.edu

Received August 24, 2004; revision received November 16, 2004; accepted December 3, 2004.

Background— Heat-shock proteins (Hsps) have been shown to render cardioprotection from stress-induced injury; however, little is known about the role of another small heat-shock protein, Hsp20, which regulates activities of vasodilation and platelet aggregation, in cardioprotection against ischemia injury. We recently reported that increased expression of Hsp20 in cardiomyocytes was associated with improved contraction and protection against ß-agonist–induced apoptosis.

Methods and Results— To investigate whether overexpression of Hsp20 exerts protective effects in both ex vivo and in vivo ischemia/reperfusion (I/R) injury, we generated a transgenic (TG) mouse model with cardiac-specific overexpression of Hsp20 (10-fold). TG and wild-type (WT) hearts were then subjected to global no-flow I/R (45 minutes/120 minutes) using the Langendorff preparation. TG hearts exhibited improved recovery of contractile performance over the whole reperfusion period. This improvement was accompanied by a 2-fold decrease in lactate dehydrogenase released from the TG hearts. The extent of infarction and apoptotic cell death was also significantly decreased, which was associated with increased protein ratio of Bcl-2/Bax and reduced caspase-3 activity in TG hearts. Furthermore, in vivo experiments of 30-minute myocardial ischemia, via coronary artery occlusion, followed by 24-hour reperfusion, showed that the infarct region–to–risk region ratio was 8.1±1.1% in TG hearts (n=7), compared with 19.5±2.1% in WT hearts (n=11, P<0.001).

Conclusions— Our data demonstrate that increased Hsp20 expression in the heart protects against I/R injury, resulting in improved recovery of cardiac function and reduced infarction. Thus, Hsp20 may constitute a new therapeutic target for ischemic heart diseases.


Key Words: ischemia • reperfusion • myocardial infarction • proteins




This article has been cited by other articles:


Home page
DiabetesHome page
L. G. Bucciarelli, R. Ananthakrishnan, Y. C. Hwang, M. Kaneko, F. Song, D. R. Sell, C. Strauch, V. M. Monnier, S. F. Yan, A. M. Schmidt, et al.
RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium
Diabetes, July 1, 2008; 57(7): 1941 - 1951.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Aleshin, R. Ananthakrishnan, Q. Li, R. Rosario, Y. Lu, W. Qu, F. Song, S. Bakr, M. Szabolcs, V. D'Agati, et al.
RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1823 - H1832.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Panner, J. C. Murray, M. S. Berger, and R. O. Pieper
Heat Shock Protein 90{alpha} Recruits FLIPS to the Death-Inducing Signaling Complex and Contributes to TRAIL Resistance in Human Glioma
Cancer Res., October 1, 2007; 67(19): 9482 - 9489.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
X. Zhou, G.-C. Fan, X. Ren, J. R. Waggoner, K. N. Gregory, G. Chen, W. K. Jones, and E. G. Kranias
Overexpression of histidine-rich Ca-binding protein protects against ischemia/reperfusion-induced cardiac injury
Cardiovasc Res, August 1, 2007; 75(3): 487 - 497.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G.-C. Fan, Q. Yuan, G. Song, Y. Wang, G. Chen, J. Qian, X. Zhou, Y. J. Lee, M. Ashraf, and E. G. Kranias
Small Heat-Shock Protein Hsp20 Attenuates {beta}-Agonist-Mediated Cardiac Remodeling Through Apoptosis Signal-Regulating Kinase 1
Circ. Res., November 24, 2006; 99(11): 1233 - 1242.
[Abstract] [Full Text] [PDF]